XBiotech, Inc. (XBIT) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

TriSalus Life Sciences, Inc.

Seer, Inc. (California)

TScan Therapeutics, Inc.

Heron Therapeutics, Inc.

Trevi Therapeutics, Inc.

Vor Biopharma, Inc.

Design Therapeutics, Inc.

Altimmune, Inc.

XBiotech, Inc.

INmune Bio, Inc.

BioVie, Inc.

Why is XBiotech, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is XBiotech, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

XBiotech, Inc.

-12.36%

-1.26

51.29%

S&P 500

20.78%

1.56

13.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

-200.91%

EBIT to Interest (avg)

-32.69

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.89

Sales to Capital Employed (avg)

0.00

Tax Ratio

0.10%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

10.68%

ROCE (avg)

ROE (avg)

39.22%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.49

EV to EBIT

1.01

EV to EBITDA

1.04

EV to Capital Employed

-3.81

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-32.45%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

PRE-TAX PROFIT(Q)

At USD -5.46 MM has Grown at 51.83%

NET PROFIT(Q)

At USD -5.5 MM has Grown at 51.65%

-16What is not working for the Company

NET PROFIT(HY)

At USD -32.4 MM has Grown at -51.44%

OPERATING CASH FLOW(Y)

Lowest at USD -42.17 MM

ROCE(HY)

Lowest at -25.93%

DEBT-EQUITY RATIO (HY)

Highest at -85.51 %

CASH AND EQV(HY)

Lowest at USD 241.01 MM

Here's what is working for XBiotech, Inc.

Pre-Tax Profit

At USD -5.46 MM has Grown at 51.83%

over average net sales of the previous four periods of USD -11.33 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

At USD -5.5 MM has Grown at 51.65%

over average net sales of the previous four periods of USD -11.38 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for XBiotech, Inc.

Operating Cash Flow

Lowest at USD -42.17 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Debt-Equity Ratio

Highest at -85.51 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Cash and Eqv

Lowest at USD 241.01 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents